Be Part of the Solution to the Opioid Crisis.
Fight Pain at Its Source – for a Pain-Free Future.
Investment opportunity for strategic partners and venture capitalists. Effective relief of peripheral pain without the usual side effects – no constipation and no addiction problems – thanks to a novel, nanotechnology-based opioid alternative. No patient should have to choose between sedation and pain.
Investment Opportunity for Strategic Partners, Venture Capitalists and Business Angels.
DendroPharm offers both the licensing of a platform technology that enables active ingredients to be delivered specifically into inflamed or tumor tissue, and the opportunity to invest directly in the company. Our NanoOpiat technology enables effective relief of severe pain without the usual central side effects of opiates – no constipation and no addiction problems. Our nanotechnology-based opioid alternative addresses both chronic and acute postoperative pain. Our vision: no patient should have to choose between sedation and pain.
Business angels interested in a larger investment of €25,000 or more are asked to contact us directly. Please use our contact form.